PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Metsä Board Oyj (METSA.HE)
5.520.06 (-1.08%)
5.46 - 5.56
4.95 - 8.28
1.7K / 2.4K (Avg.)
-276.00 | -0.02
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
5.38%
Revenue growth above 1.5x UPM.HE's 0.24%. David Dodd would confirm if the firm has a unique advantage driving sales higher.
138.16%
Positive gross profit growth while UPM.HE is negative. John Neff would see a clear operational edge over the competitor.
17.40%
EBIT growth 50-75% of UPM.HE's 34.48%. Martin Whitman would suspect suboptimal resource allocation.
17.40%
Operating income growth at 50-75% of UPM.HE's 34.48%. Martin Whitman would doubt the firm’s ability to compete efficiently.
38.46%
Net income growth 1.25-1.5x UPM.HE's 28.34%. Bruce Berkowitz would see if strategic cost cutting or product mix explains this difference.
50.60%
EPS growth above 1.5x UPM.HE's 28.57%. David Dodd would review if superior product economics or effective buybacks drive the outperformance.
50.60%
Diluted EPS growth above 1.5x UPM.HE's 28.57%. David Dodd would see if there's a robust moat protecting these shareholder gains.
-8.06%
Both firms reduce share counts. Martin Whitman would compare buyback intensity relative to free cash flow generation.
-8.06%
Both reduce diluted shares. Martin Whitman would review each firm’s ability to continue repurchases and manage option issuance.
No Data
No Data available this quarter, please select a different quarter.
-53.03%
Both companies show negative OCF growth. Martin Whitman would analyze broader economic or industry conditions limiting cash flow.
-82.66%
Negative FCF growth while UPM.HE is at 0.30%. Joel Greenblatt would demand improved cost control or more strategic capex discipline.
-30.86%
Both companies have negative long-term revenue/share growth. Martin Whitman would question if the entire market or product set is shrinking.
-27.50%
Both face negative 5Y revenue/share CAGR. Martin Whitman would suspect macro headwinds or obsolete product offerings across the niche.
-5.39%
Both firms have negative 3Y CAGR. Martin Whitman would wonder if the entire market segment is in short-term retreat.
454.41%
10Y OCF/share CAGR above 1.5x UPM.HE's 107.61%. David Dodd would check if a superior product mix or cost edge drives this outperformance.
-18.73%
Negative 5Y OCF/share CAGR while UPM.HE is at 85.84%. Joel Greenblatt would question the firm’s operational model or cost structure.
243.74%
3Y OCF/share CAGR above 1.5x UPM.HE's 48.93%. David Dodd would confirm if the firm is quickly gaining an operational edge over the competitor.
128.82%
Net income/share CAGR above 1.5x UPM.HE's 79.75% over 10 years. David Dodd would confirm if brand, IP, or scale secure this persistent advantage.
302.67%
5Y net income/share CAGR above 1.5x UPM.HE's 102.15%. David Dodd would confirm if the firm’s strategy is more effective in generating mid-term profits.
47.12%
3Y net income/share CAGR above 1.5x UPM.HE's 23.46%. David Dodd would confirm the company’s short-term strategies outmatch the competitor significantly.
No Data
No Data available this quarter, please select a different quarter.
26.22%
5Y equity/share CAGR above 1.5x UPM.HE's 8.41%. David Dodd might see stronger earnings retention or fewer asset impairments fueling growth.
27.90%
3Y equity/share CAGR above 1.5x UPM.HE's 5.19%. David Dodd verifies the company’s short-term capital management far exceeds the competitor’s pace.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
8.34%
AR growth is negative/stable vs. UPM.HE's 32.23%, indicating tighter credit discipline. David Dodd confirms it doesn't hamper actual sales.
8.60%
Inventory growth well above UPM.HE's 6.50%. Michael Burry suspects overshooting production or weaker sell-through vs. the competitor.
0.29%
Positive asset growth while UPM.HE is shrinking. John Neff sees potential for us to outgrow the competitor if returns are solid.
6.68%
Positive BV/share change while UPM.HE is negative. John Neff sees a clear edge over a competitor losing equity.
5.88%
We have some new debt while UPM.HE reduces theirs. John Neff sees the competitor as more cautious unless our expansions pay off strongly.
-100.00%
Both reduce R&D yoy. Martin Whitman sees an industry shifting to cost reduction or limited breakthroughs in the near term.
-5.58%
Both reduce SG&A yoy. Martin Whitman sees a cost war or cyclical slowdown forcing overhead cuts.